Fulgent Genetics Inc - Understand $flgt stock

$FLGT Market Cap: $677.1 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$290.7M

TTM

Gross Margin

38.6%

TTM

Net Earnings

-$163.4M

TTM

Current Assets

$399.1M

Q2 2024

Current Liabilities

$75.75M

Q2 2024

Current Ratio

526.86%

Q2 2024

Total Assets

$1.232B

Q2 2024

Total Liabilities

$103.4M

Q2 2024

Book Value

$1.129B

Q2 2024

Cash

$65.11M

Q2 2024

P/E

-4.143

Sep 13, 2024 EST

Free Cash Flow

$11.78M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$289.2M	$619.0M	$992.6M	$421.7M	$32.53M	$21.35M	$18.73M	$18.28M	$9.576M	$1.278M
YoY Change	-53.27%	-37.64%	135.37%	1196.46%	52.35%	13.99%	2.48%	90.85%	649.3%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$289.2M	$619.0M	$992.6M	$421.7M	$32.53M	$21.35M	$18.73M	$18.28M	$9.576M	$1.278M
Cost Of Revenue	$184.8M	$252.1M	$215.5M	$89.81M	$14.11M	$0.00	$8.600M	$6.722M	$5.069M	$936.0K
Gross Profit	$104.5M	$366.9M	$777.1M	$331.9M	$18.42M	$21.35M	$10.20M	$11.55M	$4.507M	$342.0K
Gross Profit Margin	36.12%	59.28%	78.29%	78.7%	56.63%	100.0%	54.46%	63.22%	47.07%	26.76%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Selling, General & Admin	$130.5M	$150.0M	$75.17M	$30.17M	$12.31M	$10.19M	$9.438M	$7.100M	$5.100M	$800.0K
YoY Change	-13.02%	99.53%	149.18%	145.02%	20.82%	7.97%	32.93%	39.22%	537.5%
% of Gross Profit	124.9%	40.88%	9.67%	9.09%	66.84%	47.73%	92.53%	61.45%	113.16%	233.92%
Research & Development	$41.44M	$28.91M	$24.22M	$11.58M	$6.537M	$5.500M	$4.200M	$3.600M	$4.400M	$521.0K
YoY Change	43.34%	19.37%	109.15%	77.15%	18.85%	30.95%	16.67%	-18.18%	744.53%
% of Gross Profit	39.67%	7.88%	3.12%	3.49%	35.49%	25.76%	41.18%	31.16%	97.63%	152.34%
Depreciation & Amortization	$26.14M	$32.66M	$11.00M	$2.962M	$2.107M	$2.163M	$1.728M	$1.200M	$600.0K	$200.0K
YoY Change	-19.96%	196.82%	271.51%	40.58%	-2.59%	25.17%	44.0%	100.0%	200.0%
% of Gross Profit	25.03%	8.9%	1.42%	0.89%	11.44%	10.13%	16.94%	10.39%	13.31%	58.48%
Operating Expenses	$300.0M	$188.4M	$99.39M	$41.75M	$18.85M	$15.72M	$13.66M	$10.64M	$9.500M	$521.0K
YoY Change	59.25%	89.53%	138.08%	121.48%	19.87%	15.1%	28.44%	11.96%	1723.42%
Operating Profit	-$195.5M	$178.5M	$677.7M	$290.2M	-$428.0K	-$5.070M	-$3.482M	$918.0K	-$4.993M	-$179.0K
YoY Change	-209.52%	-73.66%	133.55%	-67893.93%	-91.56%	45.61%	-479.3%	-118.39%	2689.39%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Interest Expense	$21.44M	$346.0K	$117.0K	$20.00K	$800.0K	$400.0K	$500.0K	-$5.400M	$0.00	$0.00
YoY Change	6097.69%	195.73%	485.0%	-97.5%	100.0%	-20.0%	-109.26%
% of Operating Profit		0.19%	0.02%	0.01%				-588.24%
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Pretax Income	-$174.1M	$184.0M	$677.3M	$291.7M	$409.0K	-$4.602M	-$3.001M	-$4.468M	-$5.000M	-$1.000M
YoY Change	-194.6%	-72.83%	132.2%	71216.38%	-108.89%	53.35%	-32.83%	-10.64%	400.0%
Income Tax	$1.154M	$42.10M	$174.8M	$72.53M	$43.00K	$36.00K	-$1.015M	$920.0K	$0.00	$0.00
% Of Pretax Income		22.88%	25.81%	24.87%	10.51%
Net Earnings	-$167.8M	$143.4M	$507.4M	$214.3M	-$411.0K	-$5.607M	-$2.510M	-$5.347M	-$8.314M	-$4.283M
YoY Change	-217.03%	-71.74%	136.74%	-52243.55%	-92.67%	123.39%	-53.06%	-35.69%	94.12%
Net Earnings / Revenue	-58.03%	23.17%	51.12%	50.82%	-1.26%	-26.26%	-13.4%	-29.26%	-86.82%	-335.13%
Basic Earnings Per Share
Diluted Earnings Per Share	-$5.64	$4.63	$16.38M	$8.892M	-$21.39K	-$311.1K	-$141.2K	-$386.9K	-$680.3K	-$247.1K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Short-Term Investments	$424.2M	$526.2M	$450.5M	$299.4M	$28.30M	$31.00M	$26.50M	$20.90M	$500.0K	$200.0K
YoY Change	-19.4%	16.81%	50.47%	957.95%	-8.71%	16.98%	26.79%	4080.0%	150.0%
Cash & Equivalents	$97.47M	$79.51M	$164.9M	$87.40M	$12.00M	$6.700M	$6.500M	$7.900M	$500.0K	$200.0K
Short-Term Investments	$326.7M	$446.7M	$285.6M	$211.9M	$16.30M	$24.30M	$20.00M	$13.00M
Other Short-Term Assets	$26.25M	$11.09M	$16.45M	$20.20M	$1.600M	$1.000M	$800.0K	$700.0K	$300.0K	$100.0K
YoY Change	136.58%	-32.56%	-18.56%	1162.5%	60.0%	25.0%	14.29%	133.33%	200.0%
Inventory
Prepaid Expenses
Receivables	$51.13M	$52.75M	$139.1M	$185.2M	$6.700M	$5.900M	$4.000M	$4.600M	$2.100M	$400.0K
Other Receivables	$6.313M	$37.79M	$5.862M	$18.90M	$500.0K	$1.600M	$1.600M	$0.00	$100.0K	$0.00
Total Short-Term Assets	$507.8M	$627.9M	$612.0M	$523.6M	$37.10M	$39.50M	$32.90M	$26.10M	$2.900M	$700.0K
YoY Change	-19.12%	2.6%	16.88%	1311.32%	-6.08%	20.06%	26.05%	800.0%	314.29%
Property, Plant & Equipment	$95.62M	$98.92M	$71.16M	$41.00M	$8.600M	$6.400M	$7.300M	$6.200M	$2.500M	$1.000M
YoY Change	-3.34%	39.01%	73.57%	376.74%	34.38%	-12.33%	17.74%	148.0%	150.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$423.6M	$326.6M	$485.0M	$132.5M	$42.80M	$7.900M	$16.80M	$25.60M
YoY Change	29.67%	-32.66%	266.07%	209.58%	441.77%	-52.98%	-34.38%
Other Assets	$43.19M	$38.94M	$23.74M	$3.300M	$300.0K	$0.00	$200.0K	$100.0K	$400.0K	$400.0K
YoY Change	10.9%	64.04%	619.36%	1000.0%		-100.0%	100.0%	-75.0%	0.0%
Total Long-Term Assets	$727.5M	$758.2M	$666.8M	$176.9M	$51.70M	$14.40M	$24.30M	$31.90M	$2.900M	$1.400M
YoY Change	-4.05%	13.71%	276.91%	242.17%	259.03%	-40.74%	-23.82%	1000.0%	107.14%
Total Assets	$1.235B	$1.386B	$1.279B	$700.5M	$88.80M	$53.90M	$57.20M	$58.00M	$5.800M	$2.100M
YoY Change
Accounts Payable	$15.36M	$23.09M	$20.49M	$26.50M	$1.600M	$1.300M	$2.100M	$2.800M	$300.0K	$200.0K
YoY Change	-33.49%	12.68%	-22.66%	1556.25%	23.08%	-38.1%	-25.0%	833.33%	50.0%
Accrued Expenses	$30.74M	$24.98M	$17.69M	$8.700M	$1.800M	$1.400M	$900.0K	$400.0K	$200.0K	$100.0K
YoY Change	23.04%	41.22%	103.32%	383.33%	28.57%	55.56%	125.0%	100.0%	100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$20.64M	$21.28M	$15.00M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-100.0%	-3.04%	41.89%
Long-Term Debt Due	$1.727M	$943.0K	$332.0K
YoY Change	83.14%	184.04%
Total Short-Term Liabilities	$73.02M	$88.11M	$105.3M	$130.1M	$3.700M	$2.700M	$3.000M	$3.300M	$700.0K	$400.0K
YoY Change	-17.13%	-16.34%	-19.05%	3416.22%	37.04%	-10.0%	-9.09%	371.43%	75.0%
Long-Term Debt	$3.760M	$1.818M	$1.398M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	106.82%	30.04%
Other Long-Term Liabilities	$11.32M	$16.42M	$5.407M	$600.0K	$2.300M	$0.00	$0.00	$0.00
YoY Change	-31.02%	203.62%	801.17%	-73.91%
Total Long-Term Liabilities	$15.08M	$18.24M	$6.805M	$600.0K	$2.300M	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-17.28%	167.96%	1034.17%	-73.91%
Total Liabilities	$99.23M	$119.4M	$120.0M	$131.1M	$6.000M	$2.800M	$3.000M	$3.600M	$700.0K	$400.0K
YoY Change	-16.87%	-0.5%	-8.49%	2085.0%	114.29%	-6.67%	-16.67%	414.29%	75.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017
Basic Shares Outstanding	29.78M	30.10M	29.41M	22.69M	18.71M	17.98M	17.74M
Diluted Shares Outstanding	29.78M	30.96M	30.98M	24.06M	18.71M	17.98M	17.74M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $677.13 Million

About Fulgent Genetics Inc

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in El Monte, California and currently employs 1,184 full-time employees. The company went IPO on 2016-09-28. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The firm also offers next-generation sequencing (NGS) services.

Industry: Services-Medical Laboratories Peers: 23andMe Holding Co. Cross Country Healthcare Inc CVS Health Corp DocGo Inc P3 Health Partners Inc Hims & Hers Health Inc ModivCare Inc RadNet Inc